Warung Bebas
Showing posts with label Neurology. Show all posts
Showing posts with label Neurology. Show all posts

Sunday, 15 July 2012

Clinical Manifestation of Polio

The following phases of the virus infection:
 
A. Acute Stage
 
That phase since the clinical symptoms up to 2 weeks. Characterized by increased body temperature. Sometimes accompanied by headache and vomiting. Paralysis caused by damage to the motor neuron cells in the spinal cord (spinal cord) due to a virus invasion. This paralysis is asymmetrical so it tends to cause a disturbance in body shape (deformity) that persist or even become more severe. Paralysis that occurs mostly in the legs (78.6%), whereas 41.4% in arm. Gradual paralysis lasted until about 2 months after the initial illness.

B. Subacute Stage
 
That phase of 2 weeks to 2 months. Characterized by the disappearance of fever within 24 hours. Sometimes accompanied by muscle stiffness and mild muscle aches. Paralysis of limbs paralyzed and usually one side only.

 
C.
Stadium Konvalescent
Long
the phase at 2 months to 2 years. Characterized by the recovery of a previously weak muscle strength. Approximately 50-70 percent of muscle function to recover within 6-9 months after the acute phase. Furthermore, after 2 years is not expected to occur again in muscle strength recovery.

 
D. Chronic Stadium
 
That is more than 2 years. Muscle paralysis that occurs is permanent.

      
Clinical picture which occur very varied ranging from the lightest to the heaviest, among other things: 
a. Infection without symptoms. 
 Incidence of asymptomatic infection, is difficult to know, but it is usually quite high, especially in areas that are poor cleanliness standards. At an endemic polio are estimated at 9-95% of the population and lead to immunity against polio. Newborns protected at first because of maternal antibodies which then would disappear after the age of 6 months. The disease is only known by a virus found in feces or elevated antibody titers.
 b. Abortive infection It was estimated 4-8% of the population in a region where the incidence is quite high. Not present the typical symptoms of poliomyelitis. Begins suddenly and lasts 1-3 days with symptoms of minor illness such as fever may reach 39.5 ° C, malaise, headache, sore throat, anorexia, vomiting, muscle pain and abdominal pain and sometimes diarrhea. The disease is difficult to distinguish from other viral diseases, only to be expected in case of polio epidemic in the region. Definitive diagnosis only by finding the virus in tissue culture. Differential diagnosis is influenza or other throat infections.

 
Non-paralytic poliomyelitis        
This disease occurs in about 1% of all infections. Clinical symptoms similar to abortive infection that lasts 1-2 days. After the temperature became normal, but then increases again (dromarychart), accompanied by symptoms of headache, nausea and vomiting is more severe, and found the back muscle stiffness in the neck, back and legs. Kernig's sign and positive brudzinsky. Another sign is when the child tried to sit down with sleeping position, then he would bend his knees up, while two support arms back on the bed. Head drop is established when the patient's body by pulling on both armpits, will cause the head fall back. Tendon reflexes are usually normal. When the tendon reflex changes, it is likely to occur paralytic poliomyelitis. The differential diagnosis of serous meningitis and meningismus are.

Paralytic poliomyelitis       
Clinical picture similar to paralytic poliomyelitis is accompanied by non weaknesses in one or more of the collection or the cranial skeletal muscles. These symptoms may disappear for several days and then comes back accompanied by paralysis (paralytic) is a flaccid paralysis' which is usually unilateral and symmetrical that is most often affected are the limbs. This may be accompanied by paralysis of the urinary vesicles, intestinal atony and sometimes paralytic ileus. In case of severe respiratory muscle paralysis can occur.

  
Clinically can be divided into four forms according to the height of lesions in the central nervous system are:
 a. Form of spinal muscular neck with symptoms of weakness, stomach, back, diaphragm, there is a limb where the majority of the lower limb. Common is the large muscles, quadriceps femoral in the leg, the arm of the deltoid. The nature of this paralysis is asymmetrical. Tendon reflexes decreases until it disappears and no disturbance of sensibility.
b. Bulbospinal form of a mixture of symptoms found between spinal and bulbar form. 
c. Bulbar form characterized by motor weakness of one or more cranial nerves with or without disruption of vital centers such as breathing, circulation and body temperature. If the weakness involves cranial nerves IX, X and XII, it will cause paralysis of the pharynx, tongue and fangs with the consequences of airway obstruction occurs.
d. Encephalytic form is characterized by a decreased consciousness, tremors and sometimes convulsions





Translate this article to Indonesian language Click Here

Related Posts
1. Types of Polio
2. How to prevent Polio
3. How Polio Transmitted
4. Therapy of Polio
 

Therapy of Polio

 
      The management of poliomyelitis Treatment in patients with polio is not specific. Treatment aims to relieve symptoms and supportive treatment to improve the stamina of the patient. Physiotherapy services need to be given to minimize the paralysis and make sure to avoid muscle atrophy. Orthopedic treatments available for those who experience persistent paralysis. The most effective disease control is prevention through vaccination and surveillance of AI P. Do rehabilitation patients to rest and put to bed, allowing the affected limb to be really comfortable. If exposed to the respiratory organs, respiratory physical therapy may be needed. If paralysis or weakness since the respiratory intensive care is required. There is no effective antiviral drugs for poliovirus, so the main therapy is to reduce complaints (supportive). Analgetic given for headache complaints. The use of ventilators in patients with respiratory muscle impairment, and an expected long-standing use of the ventilator will be performed tracheotomy. Rehabilitation therapy in patients with muscle paralysis and the wounds caused by pressure (decubitus). Giving a laxative is needed because of the lack of mobilization so that digestion will be impaired and also the provision of software and high-fiber diit. Surgical therapy in the form of merging the hip joint is required in patients with side effects of the shape or thinning disorder of the hip joint.

How to Prevent Polio

Prevention Efforts
 There are some preventive measures this spread of polio, which are:

1. Polio eradication
 World Health Assembly in 1988 which was followed by most countries around the world made an agreement to conduct Polio Eradication (ERAPO) in 2000, meaning that a polio-free world in 2000. ERAPO the first program is to do with the overall immunization coverage.
Polio immunization should be given in accordance with WHO recommendations are given at birth, 4 times at intervals of 6-8 weeks. Then repeated at the age of 1.5 years; 5tahun, and the age of 15 years. Repeated immunization efforts this would not have a negative impact. In fact it is the only program in an efficient and effective in the prevention of polio.

2. Survailance acute flaccid paralysis
 Is looking for people with suspected paralytic paralyzed at age below 15 years. They should be checked to ascertain whether the stool because of polio or not. Suspected cases of polio infection should be thoroughly checked in the laboratory because it could have happened not because of paralysis of polio.

3. Mopping Up
  This means That measures the mass vaccination of children aged under 5 years in the discovery of polio without polio Immunization previous status. It seems that in the era of globalization where the mobility of people Between countries is very high and rapid, Difficulties Arise in controlling the spread of this virus. In Addition to the prevention of polio vaccination course should be accompanied by an increase of in environmental sanitation and personal sanitation. The use of family latrines, clean water meets health requirements That, and maintain food hygiene is an effort to Prevent and Reduced the risk of transmission of polio virus That is alarming again. Being one of the world's concern That the disability Caused by polio persist can not be cured. Healing can do very little alias no cure for polio. However, the actual parents should not panic if the baby and his son had obtained a complete polio vaccination.

Polio vaccine
There are two kinds of polio vaccine, oral polio vaccine were found Albert Sabin and the polio vaccine developed by Jonas Salk is disabled, which is as follows
.
a. Oral polio vaccine
→ Cast into the mouth. Contains live polio virus that had been weakened ..
Polio Oral Vaccine


b. Inactivated polio vaccine
→ administration by injection. Contains a killed polio virus. Virus polio (poliomyelitis) is highly contagious and incurable. This virus attacks the entire body (including muscles and nervous system) and can cause permanent muscle weakness and total paralysis in a matter of hours. Even sekitar10-15 percent of those affected eventually died of polio that attacked the respiratory muscles. Until now has not found a way of treatment of poliomyelitis. The most effective way of prevention is immunization.
Polio Injection Vaccine



Translate this article to Indonesian language   Click Here  

Related Posts
1. Types of Polio
2. Clinical Manifestation of Polio
3. How Polio Transmitted
4. Therapy of Polio

How Polio Transmited

Poliomyelitis caused by polio virus. One in 200 infections develop into paralysis. A total of 5-10 percent of patients paralyzed, died when his breathing muscles become paralyzed. Mostly affects children under the age of three years (more than 50 percent of cases), but can also affect adults. Prevention by vaccination at regular intervals, ideally in childhood.

Viruses enter through the mouth and nose and then multiply in the throat and digestive tract or gut. Furthermore, absorbed and spread through the blood vessels and lymph vessels.
Direct transmission of the virus occurs in several ways, namely:

a. faecal-oral route (from feces to mouth)
 Through drink or food contaminated polio virus from stool of patients and into the mouth of healthy individuals.
b. Oral-oral (from mouth to mouth)
transmission through saliva splashes into the mouth of the patient that other healthy people. Actually, the high temperature conditions can quickly turn off the virus. Conversely, in a frozen state or a low temperature it can survive the virus for years.
Virus resistance in soil and water depends on temperature and humidity of other microbes. The virus can survive longer in the waste water and surface water, even up to miles and miles from the source of infection. Polio virus is highly resistant to alcohol and lisol, but sensitive to formaldehyde and chlorine solution. High temperatures quickly kill viruses, but in a frozen state can last for years. Virus resistance in soil and water depends on temperature and humidity of other microbes. The virus can survive for long in the waste water and surface water, even up to miles and miles from the source of infection. Although the infection is mainly due to environmental contamination by the polio virus from patients with infectious, the virus that lives in a limited environment. One of the intermediate host or organism that can be demonstrated to date is a human.





Translate this article to Indonesian language   Click Here  

Related Posts
1. Types of Polio
2. Clinical Manifestation of Polio
3. How to Prevent Polio
4. Therapy of Polio

Types of Polio

Polio
        Poliomyelitis, or polio, is a paralysis or paralytic disease caused by viruses. Carrier agent, the disease is a virus called poliovirus (PV), enters the body through the mouth, infecting the intestinal tract. The virus can enter the bloodstream and flows into the central nervous system causing muscle weakness and sometimes paralysis.

The word "polio" is derived from [Greek] or its more recent, from the "gray" and "spotting". Polio disease caused by infection with polio virus derived from the genus Enterovirus and the family Picorna viridae. The virus is transmitted through the feces (stool) or throat secretions of infected people. Polio virus entered through saliva causing infection.
This can happen easily if hands are contaminated or contaminated objects inserted into the mouth and throat and multiply in the gut. Proliferated for 4 to 35 days, then issued through the feces for several weeks later.

Polio


Types of Polio
 1. Non-polio paralysis
      Non-polio paralysis causes fever, vomiting, abdominal pain, lethargy, and sensitive. Muscle cramps occur in the neck and back, the muscles are soft to the touch.

2. Polio paralysis spinal
      Strain of poliovirus attacks the spinal cord, destroying the anterior horn cells which control movement of the trunk and limb muscles. Although this strain can cause permanent paralysis, less than one in 200 people will experience paralysis. Paralysis occurs most often found in the legs to the feet.
      After the polio virus attacks the intestines, the virus will be absorbed by the capillary blood vessels in the intestinal walls and transported throughout the body. Polio virus attacks the spinal cord and motor neurons - which control the physical movement. At this period, like-iflu symptoms appear. However, in patients who have no immunity or has not been vaccinated, the virus usually will attack all parts of the trunk spinal cord and brain stem. This infection affects the central nervous system - spreading along nerve fibers. Along with the proliferation of virus in the central nervous system, the virus destroys motor neurons. Motor neurons do not have the ability to regenerate and muscles associated with it will not react to commands from the central nervous system. Paralysis in the legs causes the legs to be weak - a condition called acute flaccid paralysis (AFP). Severe infection of the central nervous system can cause paralysis of the trunk and muscles of the thorax (chest) and abdomen (stomach), is called quadriplegia.

3. Bulbar polio
       Caused by the lack of natural immunity to develop part of the brain stem. The brain stem contains motor neurons that regulate breathing and cranial nerves, which send signals to various nerves that control eye movement; trigeminal nerve and facial nerve associated with the cheeks, tear glands, gums, and muscles of the face; auditory nerves that regulate hearing; glossofaringeal nerve that helps the process of swallowing and the various functions of the esophagus; movement of the tongue and taste, and the nerves that send signals to the heart, intestines, lungs, and additional nerve that regulates the movement of the neck. Without a ventilator, bulbar polio can cause death. Five to ten percent of patients suffering from bulbar polio will die when their breathing muscles, can not work. Death usually occurs after damage to the cranial nerves are on duty to send 'command breathed' into the lungs. Patients can also die because of damage to the swallowing function; victim can 'sink' in his own secretions unless carried out or were subjected to tracheostomy suction to suck up the fluid that is secreted before it goes into the lungs
         However, tracheostomy is also hard to do if the patient has been using the iron lung.  This tool helps the weak lungs by increasing and reducing the air pressure inside the tube. If the air pressure increased, the lung will deflate, if air pressure is reduced, the lungs will expand. Thus the air pumped out of the lungs. A much more severe infection in the brain can lead to coma and death. Bulbar polio death rate ranges from 25-75% depending on the age of the patient. Until now, those who survive this type of polio have to live with an iron lung or respirator. Bulbar and spinal polio often attacked simultaneously and is a subclass of polio paralysis. Polio paralysis is permanent. Patients who recover may have near-normal body functions.





Translate this article to Indonesian language   Click Here  

Related Posts
1. How to Prevent Polio
2. Clinical Manifestation of Polio
3. How Polio Transmitted
4. Therapy of Polio

Friday, 28 October 2011

Treatment and Therapy of Parkinson's Disease

Governance of Parkinson's disease
Parkinson's disease is a chronic disease that requires treatment in a holistic manner covering various fields. At this time there is no treatment to cure this disease, but treatment and surgery can overcome the symptoms that arise. Individualized treatment of Parkinson's disease and symptomatic, medication is usually given for the treatment of disease or to replace or mimic dopamine which will improve tremor, rigidity, and slowness.
 Treatment in patients with Parkinson's disease aims to slow and inhibit the progression of the disease. This treatment can be performed by administering medication and physical therapy such as walking therapy, sound therapy / speech and the patient is expected to keep doing daily activities.

1. Therapeutic Medicines
          Some medicines given to people with Parkinson's disease:
a. Anticholinergic Benzotropine (Cogentin), trihexyphenidyl (Artane).
Useful for controlling symptoms of Parkinson's disease. To smooth the movement.
b. Carbidopa / levodopa
Levodopa is the main treatment for Parkinson's disease.
In the brain levodopa is converted to dopamine. L-dopa is converted to dopamine in dopaminergic neurons by L-aromatic amino acid decarboxylase (dopadekarboksilase). However, only 1-5% of L-Dopa into dopaminergic neurons, the remainder is metabolized in any place, resulting in extensive side effects. Because the feedback mechanism, there would be inhibition of endogenous formation of L-Dopa. Carbidopa and benserazide are dopa-decarboxylase inhibitor, helps prevent the metabolism of L-Dopa before it reaches the dopaminergic neurons. Levodopa to reduce tremor, stiffness of muscles and improve movement. Patients with mild Parkinson's disease can return to normal activity medicine is administered with carbidopa to enhance their effectiveness and reduce side effects. Since its introduction late 1960s, levodopa is considered one of the most widely used medicines to date. Levodopa is considered the backbone of the treatment of Parkinson's disease. Thanks to levodopa, a Parkinson's patient can return to normal activities. Many physicians delay treatment with levodopa symptomatic until it is needed. If the patient's symptoms are mild and do not interfere, with levodopa therapy should not be done. It is given that the effectiveness of levodopa is associated with long time usage. Levodopa across the blood-brain-barrier and enters the central nervous system and enzymatic changes into dopamine. Inhibit the activity of dopamine neurons in the basal ganglia. Side effects of levodopa can be:
1) Nausea, vomiting, abdominal distress
2) Postural hypotension
3) Once in a while will get cardiac arrhythmias, especially in patients who are elderly. This effect is caused by beta-adrenergic effects of dopamine on the cardiac conduction system. This bias treated with beta blockers such as propranolol.
4) dyskinesia. Dyskinesias are most commonly found involving the limbs, neck or face. Dyskinesia often occur in patients who respond well to levodopa therapy. Some patients showing symptoms of an on-off which is very annoying because people do not know when a sudden movement to a standstill, frozen, hard. So the movement for a moment interrupted.
5) laboratory abnormalities. Granulocytopenia, abnormal liver function and increased blood urea is a rare complication of levodopa therapy. Side effects of levodopa on the use of many years is dyskinesia is not controlled motor movements in the limbs and body. Response of patients who take levodopa also progressively reduced. To eliminate the side effects of levodopa, the schedule of regulated and increased the dose, also by providing additional medicines that have different mechanisms such as dopamine agonists, COMT inhibitors or MAO-Binhibitor. If the combination of these medicines also not helping here considered the treatment of surgery.
Surgery is not a standard treatment for Parkinson's disease is also not as a replacement therapy to medication taken.
c. COMT inhibitors Entacapone (Comtan), tolcapone (Tasmar).
To control the motor fluctuations in patients taking the medicine levodopa. Tolcapone is a COMT enzyme inhibitor, prolonging the effects of L-Dopa. But because of excessive side effects such as liver toxic, it is rarely used. The same type, entacapone, does not cause decreased liver function.
d. Dopamine agonists.
Dopamine agonists such as bromocriptine (Parlodel), pergolid (Permax), pramipexol (Mirapex), ropinirol, cabergoline, and lisurid apomorfin considered effective enough to treat symptoms of Parkinson's. This medicine works by stimulating dopamine receptors, but this medicine also causes a progressive decrease in dopamine receptors which in turn will lead to increased symptoms of Parkinson's.
These medicines can be useful for treating patients who have experienced attacks and dyskinesia fluctuate as a result of high doses of levodopa. Apomorfin can be injected subcutaneously. Low dose is given every day can reduce the fluctuations in motor symptoms.
e. MAO-B inhibitors selegiline (Eldepryl), Rasagaline (Azilect).
MAO inhibitors are thought to be useful in Parkinson's disease because dopamine neuotransmisi can be improved by preventing damaging. Selegiline can also slow the worsening of Parkinson's syndrome, levodopa therapy thus may be deferred for some time. Useful for controlling symptoms of Parkinson's disease. That is to smooth the movement.
 Selegilin and rasagilin menginhibisi reduce symptoms with a monoamine oxidase B (MAO-B), thereby inhibiting dopamine released by the destruction of dopaminergic neurons. Metabolites contain L-L-amphetaminand methamphetamines. The side effects are insomnia. Combination with L-dopa can increase mortality, which until now has not explained clearly biased. Another effect of this combination is stomatitis.
 f.Amantadine (Symmetrel)
Useful for the treatment of akinesia, dyskinesia, rigidity, tremor.
g. Inhibitor of dopa and levodopa decarboxylation
To prevent the levodopa is changed into dopamine outside the brain, levodopa combined with dopa decarboxylase enzyme inhibitor. For this purpose can be used karbidopa or benserazide (madopar). Dopamine and karbidopa can not penetrate the blood-brain-barrier. Thus, more levodopa that can penetrate the blood-brain-barrier, and then converted into dopamine in the brain. The side effects generally similar to side effects caused by levodopa.

2.Deep Brain Stimulation (DBS)
           In 1987, the treatment was introduced by inserting an electrode that emits a high frequency electrical impulses continuously into the brain. This therapy called deep brain stimulation (DBS). DBS is a minimally invasive disurgerykan actions through guidance computer with minimal damage to graft a medical device called a neurostimulator to generate electrical stimulation to targeted areas in the brain involved in controlling movement.
        This therapy provides a low electrical stimulation in the thalamus. This stimulation is driven by implantable medical devices that suppress tremor. This therapy offers the possibility of an emphasis on all the symptoms and side effects, doctors target areas subthalamic nucleus (STN) and globus pallidus (GP) as the electrical stimulation. Choice of target areas, depending on clinical assessment. DBS is now offering new hope for a better life with the latest surgical advances to patients with Parkinson's disease. DBS is recommended for patients with advanced Parkinson's disease (stage 3 or 4) that deliver the response to levodopa. Control of parkinsonism with DBS therapy showed 90% success. Based on research, as many as 8 or 9 out of 10 people using DBS therapy to achieve an increase in the ability to perform normal daily activities.
In addition to medicine therapy is given, feeding should really be considered, because it can cause muscle stiffness sufferers have difficulty swallowing so that it can happen malnutrition (malnutrition) in patients. Fiber foods will help reduce digestive disorders caused by lack of activity, fluids and some medications.

3. Physical Therapy
             The vast majority of people with Parkinson's will feel good effects of physical therapy. Patients will be motivated so that this therapy can be done at home, with examples given instructions or training in physical therapy clinics. Program of physical therapy in Parkinson's disease is a long-term program and the type of therapy tailored to the development or worsening of disease, such as changes in rigidity, tremor and other obstacles. Regular physical exercise, including yoga, tai chi, or dance can be beneficial in maintaining and improving mobility, flexibility, balance, and range of motion. Basic training is always recommended, such as carrying bags, wearing a tie, chewing hard and move the food in the mouth.

4. Sound therapy
        The greatest care for the sound mess caused by Parkinson's disease is the Lee Silverman Voice Treatment (LSVT). LSVT focus to increase the volume. One study found that electronic devices that provide sensory feedback listener or frequency auditory feedback (FAF) to improve the clarity of sound.

5. gene Therapy
          At this present time, investigations have been carried out up to the stage of gene therapy that involves using a harmless virus that is sent to the brain called the subthalamic nucleus (STN). Genes used for mempoduksi ordered an enzyme called glutamic acid decarboxylase (GAD), which accelerates the production of neurotransmitters (GABA). GABA acts as a direct inhibitor of cell that is too active in other STN.Terapi being developed is GDNF. Infusion of GDNF (glial-derived neurotrophic factor) in the basal ganglia using kathether implants through surgery. With a variety of biochemical reactions, GDNF stimulates the formation of L-dopa.

6. nerve grafting
           Stem cell grafts genetically to produce dopamine or stem cells turn into dopamine producing cells have begun to do. The first experiment was conducted randomized double-blind sham-placebo with dopaminergic transplants that failed to demonstrate improved quality of life for patients under age.

7. Surgery
           Surgery for Parkinson's sufferers rarely done since the discovery of levodopa. Surgery performed on patients with Parkinson's who have severe where medicine therapy is inadequate. Surgery performed thalamik thalatotomi and stimulation.

8. neuroprotective therapy

           Neuroprotective therapy may protect neurons from cell death induced disease progression. Which is being developed as a neuroprotective agent is apoptotic medicines (CEP 1347 and CTCT346), lazaroids, bioenergetics, anti-glutamatergic agents, and dopamine receptors. As for which is often used in clinics are monoamine oxidase inhibitors (selegiline and rasagiline), dopamine agonists, and complek I mitochondrial fortifier coenzyme Q10.

9.Nutrisi
         Some nutrients have been tested in a clinical study clinic to then widely used to treat Parkinson's patients. For example, L-tyrosine, which is an L-dopa perkusor mennjukkan effectiveness of about 70% dalammengurangi symptoms of this disease. Iron (Fe), an essential cofactor in the biosynthesis of L-dopa reduced 10% - 60% of symptoms in a study of 110 patients.
 THFA, NADH, and piridoxin perkusor which is a coenzyme and coenzyme in the biosynthesis of dopamine showed a lower efficacy than L-tyrosine and iron. Vitamin C and vitamin E high doses can theoretically reduce cell damage that occurs in Parkinson's patients. Both vitamins are required in the enzyme activity of superoxide dismutase and catalase to neutralize superoxide anions that can damage cells. Not long ago, Coenzyme Q10 has also been used in a manner similar to working with vitamin A and E. MitoQ is a new synthetic substance that has a similar structure and function of coenzyme Q10.

10. qigong
         There are two studies of qigong in Parkinson's disease. In experiments in Bonn, a study of 56 patients found an increase in non-motor symptoms and motor skills among patients who did qigong structured 1 time a week for 8 weeks.
  However, both studies showed no effective qigong in Parkinson's disease. In the study, researchers used a randomized cross-over trial comparing aerobic exercise with qigong in advanced stages of Parkinson's disease. two groups of PD patients were assessed, then do 20 sessions both aeronik and qigong exercises, graded again, then after a lapse of 2 months, exchanged with 20 other sessions, and then assessed again. Authors obtain an increase in motor skills and function cardiopulmonal after following aerobic exercise, but do not have the benefit after attending qigong.

11.Botox
         More recently, Botox injections are being investigated as one of the treatment of non-FDA in the future

Thursday, 27 October 2011

Clinical Symptoms of Parkinson

Clinical symptoms
Although symptoms are presented below not only belong to people with Parkinson's disease, Parkinson's sufferers usually experience it.

1. Motor symptoms
a. tremor
Symptoms of Parkinson's disease often escape from the ordinary sight, and is regarded as an ordinary thing occurs in older people. One hallmark of Parkinson's disease is a hand tremors (shaking) if it is resting. However, if the person is asked to do something, the vibration was not seen again. That's called a resting tremor, which disappeared when sleep. Tremor also found on the fingers, tremors metacarpofalangis rough on the joints, sometimes tremors such as counting coins or scavenged (pill rolling). On the hand joints flexion-extension or pronation-supination in the foot flexion-extension, head flexion-extension or shook his head, mouth open to close, tongue lolling out-interested. This tremor disappeared breaks and intense emotions aroused time (resting / alternating tremor). Tremor not only occurs on the hands or feet, but can also occur on the eyelids and eyeballs, lips, tongue and fingers (such as people counting money). All this occurred during recess / unknowingly. In fact, the patient's head can be swayed if not doing the activity (unconsciously). That is, if realized, could stop tremors. At first tremor occurred only on one side, but the more severe the disease, tremors can occur on both sides.
b. Rigidity / stiffness
Another sign is the stiffness (rigidity). If the tremors fist is driven (by others) is slowly upwards resting on the wrist, there was such resistance through a toothed wheel so that the motion be broken / dotted. In addition to the hands and feet, stiffness it can also occur in the neck. Due to the stiffness, the movements become smooth again like break-dancing. Rigid motion makes the patient will walk with a hunched posture. To maintain its center of gravity to keep from falling, the pace is fast but shallow. Hipertoni presence on extensor and flexor muscles hipertoni whole movement, this is due to increased activity by alpha motorneuron, the phenomenon of toothed wheels (cogwheel phenomenon).
c.Akinesia / Bradykinesia
Both of the above symptoms are usually still less attention to signs of akinesia / bradykinesia appeared. Movement of people with a slow-paced. In the daily work can be seen in the Writings / signatures Become Smaller, harder wearing clothes, step into a short and dragged. Awareness still good, so people can Become depressed (stress) due to the disease. The face became expressionless. Wink and glance of the eye is reduced, a small voice, swallowing reflex is reduced, so often out of water liur.Gerakan volunteer to be slow so that the reduced associative movement, for example, difficult to wake up from a chair, difficulty starting to walk, slow retrieve an object, when speaking of motion of the tongue and lips become slow. Bradykinesia result in reduced expression of the face and expression and decreased spontaneous movement, such as face masks, eye blink is reduced, the reduced motion so that the saliva swallowed like out of the mouth.
d. Suddenly Stopped or Hesitate to Stepping
Another symptom is freezing, which stops in place when going to start moving, walking, or a U-turn; and start hesitation, that is hesitant to start moving. Can also occur frequent urination, and constipation. Patients with a slow thinking and depression.
e. Micrografia
Handwriting gradually became small and close together, in some cases this is an early symptom.
f. Step and gait (stance Parkinson)
Walking with small steps and getting a quick shift (marchea petit pas), locally advanced head flexed to chest, shoulders bent forward, her back arched when walking.
g. talk monotonous
This is due to bradykinesia and rigidity of respiratory muscles, vocal cords, laryngeal muscles, so when speaking or utter words that monotonous with subtle volume (whisper voice) is slow.
h. Dimentia
A change in mental status during the course of their illness with cognitive deficits.
i. behavioral disorders
Gradually become dependent (dependent on others), easily frightened, less assertive attitude, depression. This way of thinking and slow response to the question (bradifrenia) usually still be able to give correct answers, if given enough time.
j. Other symptoms
Both eyes blinking fiercely on palpation above the bridge of his nose (a sign of positive Myerson)

2. Non-motor symptoms
excessive Sweat
a. -Autonomous dysfunction, excessive saliva, sphincter disturbances and orthostatic hypotension. Especially incontinence, oily skin and seborrheic dermatitis-Spending a lot of urine, Altered sexual function disorders, characterized by the weakening of sexual desire, behavior, orgasm.
b. Mood disorders, Patients Often experience depression. Cognitive disturbances, slow response to stimuli
c. Sleep disorders, Patients have difficulty sleeping (insomnia)

Monday, 24 October 2011

Pathophysiology of Parkinson's Disease

pathophysiology
Two hypotheses are referred to as the mechanisms of neuronal degeneration in Parkinson's disease are: the free radical hypothesis and the hypothesis neurotoxins.
1. Free radical hypothesis. Alleged that the enzymatic oxidation of dopamine can damage neurons nigrotriatal, because this process produces hidrogren peroxide and other oxygen radicals. Although there is a protective mechanism to prevent damage from oxidative stress, but at the advanced age of this mechanism may fail.
2. Allegedly neurotoxin hypothesis of one or more kinds of neurotoxic substances play a role in the process of neurodegeneration in Parkinson's disease.
Current view, emphasizing the importance of the basal ganglia in neurophysiology plan required in performing the movement, and the part played by the cerebellum is to evaluate the information received as feedback on the implementation of the movement. Basal ganglia primary task is to collect the program for the movement, while the cerebellum monitor and rectification of errors that occur during movement of the program is implemented. One sign of extrapyramidal disorder is involuntary movement. Basic pathology included lesions in the basal ganglia (caudate, putamen, palidum, subtalamus nucleus) and brainstem (substantia nigra, nucleus rubra, locus ceruleus). Simply put, motor system disease or disorder can be divided as follows:
1.Piramidal; paralysis accompanied by an increased tendon reflexes and superficial reflexes are abnormal
2. Extrapyramidal: dominated by the presence of involuntary movements
3. Cerebellar: normal propioseptif ataxia or sensation often accompanied by nystagmus
4. Neuromuscular: paralysis is often accompanied by muscle atrophy and reduced tendon reflexes. Pathophysiology of depression in Parkinson's disease until now has not known for sure. But this theoretical allegedly associated with deficiency of serotonin, nor-adrenaline and  dopamine. Degenerate in Parkinson's disease neuronal cells that includes a variety of subcortical nuclei including the substantia nigra, ventral tegmental area, nucleus basalis, hypothalamus, pedunkulus Pontin, the dorsal raphe nucleus, locus cereleus, nucleuscentral pontine and autonomic ganglia. Severity of damage to this structure varies. At autopsy found loss of substantia nigra cells and cereleus locus varies between 50% - 85%, whereas in the dorsal raphe nucleus ranged between 0% - 45%, and the nucleus of the basal ganglia between 32% - 87%. Subcortical nuclei are a major source of neurotransmitters.. Involvement of this structure result in reduced dopamine in the caudate nucleus (reduced to 75%), putamen (reduced to 90%), hypothalamus (reduced to 90%). Norepinephrine was reduced 43% in the locus sereleus, 52% in the substantia nigra, 68% in the posterior hypothalamus. Serotonin is reduced 40% in the caudate nucleus and hippocampus, 40% in the frontal lobes and 30% in the temporal lobes, and 50% in the basal ganglia. There was also a reduction in specific nuropeptid such as Met-enkephalin, leu-enkephalin, substance P and bombesin. Changes lead to changes in neurotransmitters and neuropeptid neurofisiologic associated with changes in the atmosphere of feeling. Transmitter systems involved in this process mediates reward, motivation mechanisms, and response to stress. Dopamine system plays a role in the process of reward and reinforcement.
There was a doctor named Febiger, he put forward the hypothesis that abnormalities in neurotransmitter systems in Parkinson's disease will reduce the effectiveness of the mechanism of reward and lead to anhedonia, loss of motivation and apathy. Meanwhile, another doctor called, he emphasized the importance of the role of forebrain dopamine systems in the behavioral functions of hope and anticipation. This system plays a role in motivation and encouragement to do, so this dysfunction will lead to excessive dependence on the environment by reducing the desire to do the activity, decreased sense of ability to control themselves. Decreased ability to control feelings can manifest themselves as feeling useless and lost self-esteem. Dependence on the environment and the inability to perform the activity will lead to feelings of helplessness and despair. Serotonergic system plays a role in the regulation of mood feelings, waking regulation, aggression and sexual activity. Dysfunction of this system will cause disruption in sleep patterns, loss of appetite, decreased libido, and decreased ability to concentrate. Merging dysfunction all the elements mentioned above is the picture of classic depression syndrome.

Causes of Parkinson's disease

Everybody know who Cassius Clay aka Mohammed Ali is. Yes he was heavyweight boxer champion. In his older age, he get Parkinson's disease. what is parkinson's disease and what are causes of this disease? Modern Shaman from Medical and Health Information will explain.










DEFINITION
Parkinson's disease (paralysis agitans) or Parkinson's syndrome (Parkinsonism) is a disease / syndrome, due to disturbances in the basal ganglia caused by a decrease or absence of delivery of dopamine from the substantia nigra to the globus palidus / neostriatum (striatal dopamine deficiency).
Parkinson's disease is a progressive neurodegenerative disease that is closely related to age. This disease has a characteristic degeneration of dopaminergic neurons of substantia nigra pars compact, coupled with the inclusion intraplasma consisting of a protein called Lewy Bodies. In neurodegenerative parkinsonism also occurs in other brain regions including the locus ceruleus, raphe nuclei, nucleus basalis Meynert, hypothalamus, cortex cerebri, the motor nuclei of cranial nerves, the autonomic nervous system.

ETIOLOGY
Primary etiology of Parkinson's is unknown, There are some allegations, among them are: infection by a virus that non-conventional (yet unknown), an abnormal reaction to a virus that is common, exposure to toxic substances are not known, the occurrence of a premature or accelerated aging.
Parkinson's is caused by damage to brain cells, precisely in the substance nigre. A group of cells that regulate the movements that are not desired (involuntary). As a result, patients are not able to set up / resist movements that are not aware of. The mechanism of how the damage was not clear. Some of the things that allegedly could cause Parkinson's is as follows:
1. age:
The incidence increased from 10 per 10,000 population at the age of 50 to 200dari 10,000 population at the age of 80 years. It is associated with microglial reaction that affects neuronal damage, particularly in the substantia nigra, in Parkinson's disease.
2. geography:
Risk factors that affect this geographic difference in the numbers include the presence of genetic differences, immunity to disease and exposure to environmental factors.
3. Period:
 Fluctuations in the number of people with Parkinson's disease may be associated with each period of episodic environmental exposure, such as the infection process, industrialization or lifestyle. Data from the Mayo Clinic in Minessota, no major changes in morbidity between tahun1935 until 1990. This may be due to environmental factors are relatively less effect on the incidence of Parkinson's disease.
4. genetic:
Studies suggest a genetic mutation that contributes to Parkinson's disease. Namely mutations in the gene asinuklein the long arm of chromosome 4 (PARK1) in patients with autosomal dominant Parkinsonism. In patients with autosome recessive parkinsonism, found deletions and point mutations in the parkinson gene (PARK2) on chromosome 6. It also found the existence of mitochondrial dysfunction. A history of Parkinson's disease in a family increases the risk factor of Parkinson's disease by 8.8 times in less than 70 years of age and 2.8 times at more than 70 years of age. Although very rare, if it is caused by heredity, symptoms of parkinsonism appear at a relatively young age. Cases of genetics in the USA very little, undiscovered genetic cases were examined in 100 patients. In Europe too. Research in Germany found zero results in 70patients. Classic example of a genetic cause has been found in families in Italy because of cases of the disease occurred at the age of 46 years.
5. Environmental factors
a. Xenobiotics is closely linked to exposure to pesticides that may cause damage to mitochondria.
b. job
More people with higher metal exposure and longer.
c. infection
Suspected influenza virus exposure intrautero predesposisi factors contributed to the damage Parkinson's disease substantia nigra. Animal studies indicate the presence of damage to the substantia nigra by Nocardiaastroides infection.
d. diet
High fat and calorie consumption increases oxidative stress, one of the mechanisms of neuronal damage in Parkinson's disease. In contrast, coffee is neuroprotective.
e. head trauma
Cranio cerebral injury could cause Parkinson's disease, although its role is still not clear
f. Stress and depression
Some research suggests depression may precede motor symptoms. Depression and stress associated with Parkinson's disease because of the stress



Wednesday, 24 August 2011

Guillain Barre Syndrome Therapy and Treatment

In most patients can heal itself. treatment general is symptomatic. Although it is said that this disease can be cured itself, should be considered a long treatment time and number of disability ( sequelae ) high enough so that the treatment should still be given. The goal of therapy particular is to reduce disease severity and speed healing through the immune system ( immunotherapy ).



corticosteroids
Most studies suggest that the use of steroid preparations is not has a value of / is not useful for therapy of GBS.

Plasmaparesis
Plasmaparesis or plasma exchange aims to remove factors circulating autoantibodies. Plasmaparesis usage at GBS shows the results good, in the form of a more rapid clinical improvement, the use of the tools of breath fewer, and shorter treatment time. treatment is by replacing the 200-250 ml plasma / kg in 7-14 days. Plasmaparesis more beneficial when given during the initial symptom onset ( first week ).

Immunosuppressant treatment:
1. IV immunoglobulin
Treatment with gamma globulin is more profitable intervena compared plasmaparesis because of side effects / complications lighter. dose maintenance 0.4 g / kg weight / day for 3 days followed by dose maintenance 0.4 g / kg weight / day every 15 days until healed.
2. cytotoxic drugs
Sitotoxic drug delivery is recommended:
a. 6 mercaptopurin (6- MP )
b. azathioprine
c. cyclophosphamid
Side effects of these medications include: alopecia, vomiting, nausea and pain head.

Saturday, 13 August 2011

How To Diagnose and Prognose Guillain Barre Syndrome


After posting about the definition, etiology, and patofisiology, today Mbah Dukun Bagong, original shaman from Indonesia, will explain how to diagnose Guillain Barre Syndrome and how about prognosis. 

 
SUPPORTING EXAMINATIONS
1.  Laboratory tests
Laboratory picture shows elevation of protein levels in the cerebrospinal fluid (> 0.5 mg%) without being followed by the elevation of the number of cells in the cerebrospinal fluid, this is called cytoalbuminic dissociation.  The elevation was started at 1-2 weeks of disease onset and reached its peak after 3-6 weeks.  The number of mononuclear cells was <10 cells/mm3.  However in a minority of patients found no elevation of protein levels in cerebrospinal fluid.  There is may increasing serum immunoglobulin.  Some patients, can occur with hyponatremia caused by SIADH (syndrome Inapproriate antidiuretic hormone).

 2.  Electrophysiological examination (EMG)
Electrodiagnostic manifestations that supports to diagnosis is the slowing speed of motor and sensory nerve delivery.  Retention of elongated distal motor speed slows down delivery of f-wave, indicating a slowdown in the proximal segments and nerve roots.  In addition to supporting the diagnosis of electrophysiological examination is also useful for determining the prognosis of the disease: if found potential denervation suggests that the longer the healing of disease and did not recover completely.

 DIAGNOSIS
Commonly used diagnostic criteria are the criteria of the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS), namely:
1.  The characteristics necessary for diagnosis:
The occurrence of progressive weakness Hyporeflexia
2.  The characteristics that strongly support the diagnosis of GBS:
a.  Clinical symptoms:
Diagnosis of GBS is clinically mainly enforced.  GBS is characterized by an acute paralysis / weakness of motor progresive rapidly (maximal within 4 weeks, 50% reached the peak in 2 weeks, 80% in 3 weeks, and 90% in 4 weeks), relatively symmetrical with loss of tendon reflexes  (areflexi or hipoflexia) and preceded by paresthesias of two or three weeks after suffering a fever accompanied by dissociation cytoalbumine on liquor and mild sensory disturbances and motor peripheral.  Symptoms of cranial nerves ± 50% occurred N VII parese and often bilateral.  Other brain nerves which supply can be affected especially the tongue and muscles of swallowing, sometimes <5% of cases, starting from the muscle ekstraocculer neuropathy or other brain nerves.  Recovery: starts 2-4 weeks after progression stops, can be elongated up to several months.  Autonomic dysfunction.  Tachycardia and arrhythmia, postural hypotension, hypertension, and vasomotor symptoms.  No fever at onset of neurological symptoms.
b.  The characteristics of cerebrospinal fluid abnormalities are strongly supporting the diagnosis:
Cerebrospinal fluid protein picture of the CSS.  Increased after 1 week of symptoms or an increase in LP serial number of cerebrospinal fluid mononuclear cells <10 cells / mm.
Variants:
1) No increase in protein after 1 week of symptom CSS
2) The number of cells CSS: 11-50 MN/mm3
c.  EMG examination
Electrodiagnostic picture that supports the diagnosis: there is a slowdown in the speed of conductivity / nerve conduction block on EMG even in 80% of cases.  Usually the speed of carrying about 60% of normal.


DIFFERENTIAL DIAGNOSIS
1.  Asymmetric paralysis that persisted.
2.  Bladder and bowel disorders are settled.
3.  Bladder and bowel disturbances at onset.
4.  The number of mononuclear cells in cerebrospinal fluid> 50 cells mm3.
5.  There PMN leukocytes in the cerebrospinal fluid.
6.  Impaired sensibility demarcated.
7.  Poliomyelitis, botulism, hysteria or toxic neuropathies (eg due to lead poisoning / lead, itrofurantoin, dapsone, organophosphates), Diphtheric paralysis, miller-fisher syndrome, cranial sensory deficit, Pandisautonomia pure, Chronic demyyelinative acquired neuropathy, acute intermittent Porphyria.

 Prognosis
Before the existence of artificial ventilation approximately 20% of patients died due to respiratory failure.  Today's death ranged from 2-10%, with cause of death due to respiratory failure, impaired autonomic function, pulmonary infection and pulmonary embolism.  Most patients (60-80%) recover completely within six months.  A small percentage (7-22%) healed within 12 months with mild motor abnormalities and atrophy of the small muscles in the arms and leg. 3-5% of patients relapse.

Guillain Barre Syndrome



Synonims for Guillain Barre Syndrome are : Idiopathic polyneuritis, acute febrile polyneuritis (polineuritis febrile), infective polyneuritis, Post Infectious polyneuritis (polineuritis acute post-infection), acute inflammatory demyelinating (acute toxic polineuritis), Polyradiculoneuropathy, Guillain Barre Strohl Syndrome, Landry Ascending paralysis, and Landry Guillain Barre Syndrome. 



DEFINITION
GBS is a clinical syndrome characterized by acute paralysis that occurs is associated with the autoimmune process in which the target is the peripheral nerves, roots, and cranial nerves.
ETIOLOGY
The etiology of GBS is still not yet known certainly.  The theory adopted today is an aberration immunobiologic, both primary immune response or immune mediated process.  Latent period between infection and symptoms polineuritis gives the notion that the abnormalities are likely caused by an allergic reaction in response to peripheral nerve.  In many cases, the infection was not previously found, except sometimes the peripheral nerves and ventral and dorsal spinal cord, there were also disturbances in the spinal cord and medulla oblongata.
Some conditions / diseases that precede and perhaps something to do with the occurrence of GBS, among others:
1.  Viral or bacterial infection
GBS often associated with acute non-specific infection.  Incidence of GBS cases associated with this infection approximately between 56% - 80%, ie 1 to 4 weeks before neurological symptoms occur such as upper respiratory tract or gastrointestinal infection.  Acute infections are associated with GBS:
a.  Viruses: CMV, EBV, HIV, varicella-zoster virus, Vaccinia / smallpox, influenza, Measles, Mumps, Rubella, hepatitis, Coxsackie, Echo.
b.  Bacteria: Campylobacter, Jejeni, Mycoplasma, Pneumonia, Typhoid, Borrelia B, paratyphoid, Brucellosis, Chlamydia, Legionella, Listeria.
2.  Vaccination
3.  Surgery, anesthesia
4.  Systemic diseases, such as malignancy, systemic lupus erythematosus, thyroiditis, and Addison's disease
5.  Pregnancy or the puerperium
6.  Endocrine Disorders

 CLINICAL MANIFESTATIONS
1.  Latent period
The time between infected or prodromal state that preceded it and the onset of neurological symptoms.  The length of this latent period ranged from one to 28 days, an average of 9 days.  In this latent period there has been no clinical symptoms that arise.
2.  Clinical Symptoms
a.  Paralysis
The main clinical manifestation is the paralysis of the muscles of the lower extremity motor neurone type of muscles of extremities, body and sometimes also the face.  In most patients, paralysis of both lower extremities begins later spread asenderen to the body, upper limbs and cranial nerves.  Sometimes it can also be subjected to all four limbs simultaneously, and then spread to the body and cranial nerves.  Paralysis of these muscles and is followed by a symmetrical or arefleksia hyporefleksia.  Usually the degree of paralysis of the muscles of the proximal portion is more severe than the distal, but it can also same, or distal parts more severe thanproximal part.
b.  Impaired sensibility
Paresthesias are usually more obvious on the distal extremities, the face can also be charged with distribution sircumoral.  Objective sensory deficit is usually minimal and often with the pattern of distribution such as socks and gloves.  Ekstroseptif sensibility more commonly affected than on proprioceptive sensibility.  Muscle pain often encountered after physical activity.
c.  Cranial nerve
Cranial nerve is most commonly affected is N. VII.  Paralysis of the facial muscles often begins on one side but then soon became bilateral.  All the cranial nerves may be subject except NI and N. VIII.  Diplopia can occur as a result of N. N. IV or III exposed.  When the N. IX and NX exposed will cause a disruption in the form of difficult swallowing, dysphonia and in severe cases cause respiratory failure due to n.  laryngeal paralysis.
d.  Impaired autonomic function
Impaired autonomic function is found in 25% of patients with GBS.  The disorder is a tachycardia or bradycardia less frequently, red face (facial flushing), fluctuating hypertension or hypotension, loss of sweating or episodic profuse diaphoresis.  Urinary retention or urinary incontinence is rarely encountered.  Autonomic disorders are rarely settled more than one or two weeks.
e.  Respiratory failure
Respiratory failure is a major complication that can be fatal if not treated properly.  Respiratory failure caused by paralysis of the diaphragm and the paralysis of respiratory muscles, which is found in 10-33 percent of patients.
f.  Papilledema
Sometimes found papilledema, the cause is not known with certainty.  Presumably because the elevation levels of protein in the muscles that cause blockage of fluid arachoidales villi that absorption of cerebrospinal fluid is reduced.

PATHOPHYSIOLOGY
Myelinated axons conducts of nerve impulses faster than the unmyelinated axons.  Along the way the myelinated fibers interference occurs in the membranes (node Ranvier) where direct contact between the membrane of axons of cells with extracellular fluid.  Highly permeable membrane at the node, so that conduction be good.  Movement of ions into and out axons can occur rapidly only at the Ranvier nodes, so that impulses along nerve fibers bermielin can jump from one node to another node (conduction salsatori) with sufficiently strong.  In GBS, the myelin membranes that surround the axons lost.  Myelin membrane is quite susceptible to injury because many agents and conditions, including physical trauma, hypoxemia, toxic chemicals, vascular insufficiency, and immunological reactions.  Demyelination is a common response of neural networks against many adverse conditions.  Loss of myelin fibers in Guillain - Barre Syndrome makes salsatory conduction unlikely to occur, and the transmission of nerve impulses
canceled.  Mechanisms of how infections, vaccinations, trauma, or other factors that precipitate the occurrence of acute demyelination in GBS is still not known with certainty.  Many experts conclude that the nerve damage that occurs in this syndrome is through an immunologic mechanism (the process of antibody response against viruses or bacteria) that cause damage to the nervous edge to paralysis evidence that imunopatogenesis is the mechanism that causes peripheral nerve injury in this syndrome are :
1.  Obtainment of antibodies or cellular immune response (keen mediated immunity) against infectious agents on peripheral nerve.
2.  Presence of auto antibodies against peripheral nervous system
3.  Accumulation of antigen antibody complexes acquired from circulation in the blood vessels peripheral nerves causing peripheral nerve demyelination process.  Demyelination process of peripheral nerve in GBS is influenced by the response of cellular immunity and humoral immunity triggered by previous events, the most common viral infection.
Due to an infection or certain circumstances will arise that precedes GBS autoantibodies or cellular immunity against the network system peripheral nerves.  Meningococcal infections, viral infections, syphilis or trauma to the spinal cord, can lead to adhesion- arachnoid membrane attachment.  In tropical countries the cause is an infection of tuberculosis.  In certain places the attachment post-infection can ensnare ventral roots (dorsal root as well).  Because not all ventral roots exposed, but mostly on the cliquegroups , the root-root of the cervical and lumbosacral diinstrumensia are most commonly affected by the attachment of post-infection.  Therefore LMN paralysis most often found in the muscles of the limbs, the muscles around the shoulder and hip joints.  Paralysis of the arm with a sensory deficit on both legs or the muscles of the limbs.  Pathologically found myelin degeneration with edema that may or without cell infiltration.  Infiltration consisting of mononuclear cells.  These cells infiltrate mainly composed of small lymphocytes, medium and looks too, macrophages, and polymorphonuclear cells at the beginning of the disease.  After that comes the plasma cells and mast cells.  Segmental nerve fibers and axonal degeneration.  These lesions be limited to the proximal segments and spinal roots or spread along peripheral nerves.  Predilection for the spinal roots allegedly due to lack of effective permeability between the blood and nerves in the area.


Course of the disease
Natural history of GBS, the time scale and severity of paralysis varies between different patients with GBS.  The course of this disease consists of three phases, namely:
1.  Progressive phase
Starting from the onset of the disease, which during this phase of paralysis gain weight until it reaches a maximum.  This phase lasts a few from up to 4 weeks, rarely exceeding 8 weeks.
2.  Plateau phase
Paralysis has reached the maximum and settle.  This phase can be short for 2 days, most often for 3 weeks, but rarely more than 7 weeks.
3.  Phase reconvalesense
Characterized by the onset of extremity paralysis improvement that lasted for several months. Totally runs in time less than 6 months.

Tuesday, 14 September 2010

Myasthenia Gravis




DEFINITION


When Mbah Dukun surving on internet, he gets message from Nilla Gustian. Nilla wants information about Myasthenia Gravis.

What is Myasthenia Gravis?
Myasthenia Gravis (MG) is a chronic, autoimmune disease that causes muscle weakness and excessive muscle fatigue. The name comes from Greek and Latin words meaning "grave muscle weakness." But most cases of MG are not as "grave" as the name implies.

The disease can vary in severity and distribution of weakness between individuals, and in any one patient the symptoms fluctuate with relapses and remissions. MG can resolve spontaneously, but for most patients MG persists for life. It can be life threatening, but 90% of patients become symptom-free with modern treatments.
MG produces progressive weakness and fatigue and sporadic abnormal in skeletal muscles, which get worse after exercise and repetition of movement, but can be corrected with drugs antikholineterase.
Usually, this disorder that attacks the muscles controlled by cranial nerves (face, lips, tongue, neck, and throat) but can also attack other muscles.
MG followed the explosion of anger and periodic remissions that can not be predicted. Treatment was not known, but drug therapy can improve symptoms and allow patients to live relatively normal, except during the outburst occurred.
When the disease involves the respiratory system, it can endanger lives.







EPIDEMIOLOGY


Patient asks to Mbah Dukun Bagong: Who is at risk of developing MG and  Is MG hereditary?
Mbah Dukun Bagong answers:

MG affects all races and can develop at any age from childhood to extreme old age. Young patients are more commonly women, whereas older patients, over 50 years, are more often men. People who inherit a tendency to develop autoimmune disease are at increased risk of developing MG, so a patient with MG may have another autoimmune disease, such as diabetes or thyroid disease, or have a relative with autoimmune disease. Occasionally MG develops in patients with rheumatoid arthritis who are given the drug penicillamine. In these cases, the MG symptoms usually disappear when the drug is stopped.
MG is not an inherited disease and does not usually occur in families. This is in contrast to the congenital myasthenic syndromes that are genetic disorders (see below). However, it is thought that an individual’s genetic make-up is one factor, of perhaps many, that leads them to develop MG, and it may occasionally be found in more than one family member. 
Estimates of the number of people affected by MG vary, ranging from 5 to 14 people per 100,000. It occurs in all ethnic groups and both sexes. It most commonly occurs in: 
• young adult women (under 40) 
• older men (over 60)MG can occur at any age. Children sometimes develop it as well. MG is not passed down through the family. You can’t “catch it” from some-one who has it. The disease rarely occurs in more than one member of the same family. If a woman with MG becomes pregnant, sometimes the baby gets antibodies from the mother and has MG symptoms for a few weeks or months after birth. This is called neo-natal myasthenia. The symptoms can be treated and the baby does not have per-manent MG. A group of rare disorders called congeni-tal myasthenic syndromes (CMS) can pro-duce symptoms similar to MG. Unlike MG, these disorders are not autoim-mune disorders but are caused by defec-tive genes. Because of these genes, the nerve-muscle junctions in the body cannot work properly. CMS usually starts at or near birth. But it can start in childhood or even adulthood.


PATHOLOGY

Patient asks to Mbah Dukun Bagong: Tell me pathology of Myasthenia Gravis?
Mbah Dukun Bagong answers:
 
The voluntary muscles of the entire body are controlled by nerve impulses that arise in the brain. These nerve impulses travel down the nerves to the place where the nerves meet the muscle fibers. Nerve fibers do not actually connect with muscle fibers. There is a space between the nerve ending and muscle fiber; this space is called the neuromuscular junction.
When the nerve impulse originating in the brain arrives at the nerve ending, it releases a chemical called acetylcholine. Acetylcholine travels across the space to the muscle fiber side of the neuromuscular junction where it attaches to many receptor sites. The muscle contracts when enough of the receptor sites have been activated by the acetylcholine. In MG, there is as much as an 80% reduction in the number of these receptor sites. The reduction in the number of receptor sites is caused by an antibody that destroys or blocks the receptor site.
Antibodies are proteins that play an important role in the immune system. They are normally directed at foreign proteins called antigens that attack the body. Such foreign proteins include bacteria and viruses. Antibodies help the body to protect itself from these foreign proteins. For reasons not well understood, the immune system of the person with MG makes antibodies against the receptor sites of the neuromuscular junction. Abnormal antibodies can be measured in the blood of many people with MG. The antibodies destroy the receptor sites more rapidly than the body can replace them. Muscle weakness occurs when acetylcholine cannot activate enough receptor sites at the neuromuscular junction. 






SYMPTOMS



Patient asks to Mbah Dukun Bagong: How can we know MG symptoms?
Mbah Dukun Bagong answers:



Dominant symptoms of this disease are skeletal muscle weakness and fatigue. In the early stages, certain muscles are susceptible to fatigue, but no other symptoms. Ultimately, this phenomenon is getting worse and can cause paralysis.Normally, muscles felt strong in the morning and weakened throughout the day, especially after exercise. Short break for a while can restore muscle function. Growing muscle weakness; finally some muscle to not function at all. Symptoms that occur depending on the affected muscle groups; this phenomenon is increasingly becoming the menstrual period and after emotional stress, too long in the sun or the cold or infection.The appearance of symptoms can occur suddenly or from within. In many patients, weak eye closure, the closed eyelids, and double vision is the beginning of this disorder. Patients usually have nasal regurgitation of fluids that often occurs and difficulty chewing and swallowing.Because of this disorder, sufferers are often afraid of choking. Patients also experienced difficulty breathing. Because the eyelids are closed, the patient should raise his head to look toward the back, neck muscles become too weak to support the head without being short.Miastenik crisis patients (respiratory disturbance that appears suddenly) can be susceptible to pneumonia and other respiratory tract infections. This situation can get worse so that it requires mechanical ventilation and airway emergency.





 DIAGNOSE


Patient asks to Mbah Dukun Bagong: How to Diagnose?
Mbah Dukun Bagong answers:



The history and examination of the patient can suggest the diagnosis but it is important to confirm the diagnosis by special investigations: Antibodies to the acetylcholine receptor are found in 85% of patients with generalised MG, and 50% of patients with ocular MG. They are detected by a blood test.
Electromyography (EMG) is performed by a specialist doctor and involves measuring the electrical response in the muscle with a very fine needle. An electrical stimulus is applied to a nerve and the response in the muscle is recorded. It is a very sensitive test, showing an abnormality in most patients with MG, but is not available at all hospitals.
Tensilon® test, an injection of Edrophonium is given which results in a rapid but short-lived improvement in symptoms in many patients.
Chest scan should be done to check whether the thymus is abnormal as many patients with MG have an enlarged thymus, and some have a benign tumour.






Treatments for Myasthenia Gravis (MG)



Patient asks to Mbah Dukun Bagong: How to manage patient with Myasthenia Gravis?
Mbah Dukun Bagong answers:


 There is no known cure for MG, but there are effective treatments that allow many-but not all-people with MG to lead full lives. Common treatments include medications, thymectomy and plasmapheresis. Spontaneous improvement and even remission may occur without specific therapy.
Medications are most frequently used in treatment. Anticholinesterase agents (e.g., Mestinon®) allow acetylcholine to remain at the neuromuscular junction longer than usual so that more receptor sites can be activated. Corticosteroids (e.g., prednisone) and immunosuppressant agents (e.g., Imuran®) may be used to suppress the abnormal action of the immune system that occurs in MG. Intravenous immunoglobulins (IVIg) are sometimes used to affect the function or production of the abnormal antibodies also.
Thymectomy (surgical removal of the thymus gland) is another treatment used in some patients. The thymus gland lies behind the breastbone and is an important part of the immune system. When there is a tumor of the thymus gland (in 10-15% of patients with MG), it is always removed because of the risk of malignancy. Thymectomy frequently lessens the severity of the MG weakness after some months. In some people, the weakness may completely disappear. This is called a remission. The degree to which the thymectomy helps varies with each patient.
Plasmapheresis, or plasma exchange, may be useful in the treatment of MG also. This procedure removes the abnormal antibodies from the plasma of the blood. The improvement in muscle strength may be striking, but is usually short-lived, since production of the abnormal antibodies continues. When plasmapheresis is used, it may require repeated exchanges. Plasma exchange may be especially useful during severe MG weakness or prior to surgery.
Treatment decisions are based on knowledge of the natural history of MG in each patient and the predicted response to a specific form of therapy. Treatment goals are individualized according to the severity of the MG weakness, the patient's age and sex, and the degree of impairment. 






References:


1. http://forum.um.ac.id

2. http://www.myasthenia.org

3. http://www.mdi.ie

4. http://www.neurology.org

5. http://www.wrongdiagnosis.com

6. http://jama.ama-assn.org
 

Medical and Health Information Copyright © 2012 Fast Loading -- Powered by Blogger